| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Xanthinol |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Nylidrin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Inositol hexanitrate |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| vascormone |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dioxyline |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Hydralazine hydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Trolnitrate phosphate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Eritrityl tetranitrate |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Khellin |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Beta pyridyl carbinol (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Unclassified vasodilating agent |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Heptaminol |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Betahistine dihydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Peripheral/cerebral vasodilator |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Nitrate-based vasodilating agent (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Tolazoline |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Papaverine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanadrel (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by vasodilator |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
| Coronary vasodilator poisoning NOS |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Other vasodilator poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Other vasodilator poisoning NOS |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by coronary vasodilator |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
| Product containing sodium nitroprusside |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intra-cavernosal vasodilator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| vasodilatateur intraveineux |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intra-arterial vasodilator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Accidental diazoxide poisoning (disorder) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intentional diazoxide poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| intoxication par la diazoxide d'intention indéterminée |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Accidental dipyridamole poisoning (disorder) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intentional dipyridamole poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| intoxication par le dipyridamole d'intention indéterminée |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Accidental nitrite poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intentional nitrite poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Nitrite poisoning of undetermined intent |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Vasodilator adverse reaction |
Causative agent (attribute) |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
| Vasodilator antihypertensive drug adverse reaction |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Sodium nitroprusside adverse reaction |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Flosequinan adverse reaction |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Diazoxide adverse reaction |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole adverse reaction |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Alpha blocking vasodilator adverse reaction |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Thymoxamine adverse reaction (disorder) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Allergy to vasodilator |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Vasodilator antihypertensive drug allergy |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| allergie au nitroprussiate de sodium |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Allergy to flosequinan (finding) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Allergy to diazoxide (finding) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Allergy to dipyridamole (finding) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Alpha blocking vasodilator allergy |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Allergy to moxisylyte |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Vasodilator overdose |
Causative agent (attribute) |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
| Diazoxide overdose |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Accidental diazoxide overdose |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intentional diazoxide overdose |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| surdose de diazoxide d'intention indéterminée |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole overdose |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Accidental dipyridamole overdose |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intentional dipyridamole overdose |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| surdose de dipyridamole d'intention indéterminée |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Vasodilator antihypertensive drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Diazoxide [cardiovascular use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| diazoxide 15 mg/mL, ampoule de 20 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| nitroprussiate de sodium 10 mg/mL, fiole de 5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Vasodilators used in angina pectoris |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing flosequinan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Vasodilators in heart failure [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Peripheral vasodilators and related drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing moxisylyte (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Moxisylyte 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Cerebral vasodilators |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 200mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| dipyridamole 5 mg/mL, ampoule de 2 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole+aspirin 200mg/25mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing precisely betahistine 8 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Poisoning by diazoxide |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Diazoxide [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Diazoxide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Thymoxamine hydrochloride [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Thymoxamine hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Adrenaline 2 mg/mL and guanethidine monosulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 0.5%/0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Thymoxamine 0.5% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Poisoning by dipyridamole |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing guanethidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Alpha blocking vasodilator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing betahistine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing moxisylyte in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing moxisylyte in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Topical oral thymoxamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]